What is the Edinburgh Postnatal Depression Scale (EPDS), how is it scored, what cutoff scores indicate possible or probable depression, and when should it be administered during the perinatal period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Edinburgh Postnatal Depression Scale (EPDS)

The EPDS is a 10-question screening tool that assesses symptoms over the past 7 days, scored from 0-30, with a cutoff of ≥10 indicating possible depression requiring further evaluation. 1

What the EPDS Is

The EPDS is the most robustly validated and recommended screening instrument for postpartum depression, specifically developed for use in postpartum women 1. It received the only Class A recommendation among 10 evaluated screening tools based on adequate content validity, moderate evidence for internal consistency, and sufficient structural validity 1. The scale has been translated into over 60 languages and demonstrates superior psychometric properties compared to general depression screening tools 1.

Scoring System

  • Number of questions: 10 items
  • Score range: 0-30 (lower scores indicate less depression)
  • Time period assessed: Past 7 days
  • Completion time: Approximately 5 minutes 2
  • Scoring method: Each question uses different response options scored 0-3 points 1

Cutoff Scores and Interpretation

The evidence shows varying cutoff recommendations depending on the clinical context:

Standard screening cutoffs:

  • ≥10 points: Possible depression - indicates need for further evaluation 1
  • ≥11 points: Maximizes combined sensitivity and specificity across multiple studies 1
  • ≥13 points: Probable depression - suggests immediate further assessment is necessary 3

Important nuance: A detailed analysis of 58 validation studies found that a cutoff of 11 or higher optimizes the balance between sensitivity and specificity 1. However, sensitivity ranges from 34-100% and specificity from 44-100% across different studies, reflecting heterogeneity in methodology, language, and diagnostic criteria used 4.

When to Administer

Multiple timepoints are supported by evidence:

  1. At 2-3 days postpartum (delivery discharge):

    • Feasible and identifies women at risk 5
    • EPDS ≥9 at day 2-3 significantly predicts depression at 4-6 weeks postpartum 6, 7
    • 42% of women scoring ≥9 at discharge continue to score high at postpartum visit 5
    • Negative predictive value of 91.8% - most women with low scores at discharge remain low 5
  2. At postpartum day 3:

    • Scores correlate significantly with one-month scores (r = 0.476, p < 0.001) 8
    • Even scores of 5-8 (below traditional cutoff) warrant careful follow-up 8
  3. At 4-6 weeks postpartum:

    • Traditional screening timepoint
    • Remains important as 8.2% of women with low scores at discharge will convert to positive 5

Clinical Algorithm for Implementation

Screen at delivery discharge (day 2-3):

  • Score ≥9 → High risk, arrange close follow-up and consider early intervention
  • Score 5-8 → Moderate risk, provide supportive resources and rescreen at postpartum visit
  • Score <5 → Low risk, routine rescreening at postpartum visit

Rescreen at 2-6 weeks postpartum (universal):

  • Captures the 8.2% who convert from low to high risk 5
  • Score ≥10 → Further evaluation required
  • Score ≥13 → Immediate assessment and treatment planning

Key Clinical Caveats

Risk factors requiring heightened surveillance:

  • Personal history of depression (significantly associated with PPD) 7
  • Marital instability 3
  • Lack of medical insurance 3
  • EPDS ≥9 at delivery discharge 7

Critical safety consideration: Always assess question 10 regarding self-harm thoughts, regardless of total score. In one study, 2.3% endorsed self-harm at delivery discharge 5.

Limitations to recognize:

  • The EPDS is a screening tool, not a diagnostic instrument 1
  • Gold standard diagnosis requires SCID-5 or psychiatric consultation 1
  • Does not include questions about infant-related concerns 1
  • Cross-cultural validity has not been adequately evaluated despite widespread translation 1

Practical advantages:

  • Freely available (no purchase required) 1
  • Brief administration time
  • Sensitive to changes in depression severity over time 2
  • Can be completed by patients independently

The EPDS should be used by all clinicians caring for perinatal women, with screening at both delivery discharge and the postpartum visit to maximize detection while minimizing false negatives 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.